->

AMC inovhura CAR T-Cell therapy nzvimbo muSeoul

Share This Post

Jan 2023: Asan Medical Center (AMC) yakavhura nzvimbo yekutanga yekurapisa maseru eCAR-T munyika mushure mekunge hurumende yabvumidza mabhenefiti einishuwarenzi yehutano yeKymriah's CAR-T cell therapy.

AMC yakazivisa neChipiri kuti chipatara chayo chegomarara chakavhura nzvimbo yeCAR-T uye yatanga kubhadhara kurapwa kweKymriah kwakabvumidzwa naNovartis.

Asan medical centre seoul korea

Mukurapa kweCAR-T, maseru ekudzivirira (T masero) kubva kumurwere anobviswa uye anotapurwa nechimeric antigen receptors inonangana nekenza maseru. Murwere anobva abaiwa jekiseni remaT cells kuti apedze masero egomarara.

When treating patients with relapsed and refractory B-cell acute lymphoblastic leukaemia (ALL) who are 25 years of age or younger as well as individuals with refractory diffuse large B-cell lymphoma, Kymriah is covered by insurance (DLBCL).

Kudzokororwa uye refractory B-sero ALL uye kudzoka zvakare uye refractory DLBCL zvave zvakanyanya kunetsa kurapa kusvika pari zvino, neruzhinji rwevarwere ava vasina kurarama kwemwedzi mitanhatu mushure mekuongororwa.

Maererano nehuwandu, CAR-T kurapwa kunouraya gomarara mu50% yevarwere vakuru vane DLBCL yakadzokororwa uye inoramba uye inoda kusvika 80% yevarwere vevana vane kudzoka zvakare uye refractory B-cell ALL.

 

Muzvinafundo Ho Joon Im CAR T Cell therapy nyanzvi muSouth Korea

Mufananidzo: Mucheche Lee achiwana chipo cheKisimusi kubva kuna Muzvinafundo Ho Joon Im (Courtsey: Asan medical Center webhusaiti)

Varwere vakura chete ndivo vachaonekwa panzvimbo yeAMC's CAR-T nevanooncologist Yoon Dok-hyun, Cho Hyung-woo, uye vehematologist Lee Jung-hee naPark Han-seung.

Im Ho-joon, Koh Kyung-nam, Kim Hye-ry, naKang Sung-han, vana hemato-oncologists, vachapa rubatsiro kuvarwere vadiki.

Yoon Dok-hyun, director we AMC's CAR-T centre, akataura kuti kunyangwe kurapa kweCAR-T kune mhedzisiro inoshamisa, kunogona kuguma nemhedzisiro yakaipa. Kiriniki yekutanga yekurapa kweCAR-T yakagadziridzwa neAMC's CAR-T centre mukubatana nemadhipatimendi akawanda, anosanganisira intensive care unit, neurology, uye chirwere chinotapukira, kuvaka maprotocol ekuona mhedzisiro nekukurumidza uye kupa kurapwa kwakachengeteka.

 

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kurapa Kwemasero eCAR T kunoitwa nevanhu: Kubudirira Uye Zvinetso
CAR T-Cell kurapa

Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso

Human-based CAR T-cell therapy inosandura kurapwa kwegomarara nekugadzirisa magene masero emuviri emurwere kuti anange nekuparadza maseru egomarara. Nekushandisa simba rekudzivirira kwemuviri, marapirwo aya anopa marapiro ane simba uye emunhu ane mukana wekuregererwa kwenguva refu mumhando dzakasiyana dzegomarara.

arun Dai 4, 2024
Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Alysha Mendossa April 29, 2024

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Taura nesu
Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa